ORIGINAL ARTICLE: Inhibition of endocytosis activates alternative degradation pathway of [beta]APP in cultured cells
Alzheimer's disease associated [beta]APP is sequentially endoproteolyzed by alpha/[beta]-secretase and gamma-cleavage. In the process, extracellular shedding by alpha-secretase (ADAM 9/10/17) or [beta]-secretase (BACE 1/2) at position L17 or D1 (A[beta] numbering) are prerequisites for the gene...
Gespeichert in:
Veröffentlicht in: | Psychogeriatrics 2006-09, Vol.6 (3), p.107 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 107 |
container_title | Psychogeriatrics |
container_volume | 6 |
creator | FUKUMORI, Akio JIANG, Jingwei TANII, Hisashi MORIHARA, Takashi KAMINO, Kojin TANAKA, Toshihisa KUDO, Takashi ITO, Naohiro TAGAMI, Shinji OKOCHI, Masayasu TAKEDA, Masatoshi |
description | Alzheimer's disease associated [beta]APP is sequentially endoproteolyzed by alpha/[beta]-secretase and gamma-cleavage. In the process, extracellular shedding by alpha-secretase (ADAM 9/10/17) or [beta]-secretase (BACE 1/2) at position L17 or D1 (A[beta] numbering) are prerequisites for the generation of P3 or A[beta], respectively. In addition, several alternative extracellular cleavage sites in [beta]APP have been reported at position I-6, V-3, R5, E11, F20, and A21. Among these sites, position R5 is considered to be cleaved by alpha-secretase-like activity, whereas position E11, F20 and A21 are cleaved by [beta]-secretase. Therefore, extracellular shedding of [beta]APP is thought to be mediated exclusively by alpha/[beta]-secretase activities. However, so far the characteristics of cleavages at position V-3 and I-6 are not well understood. The aim of this study is to characterize these two cleavages of [beta]APP. We analyzed the conditioned media of [beta]APP wt or sw expressing cells with or without pharmacological agents. Here, we show that the cleavage at position I-6 of [beta]APP has characteristics distinct from that of alpha/[beta]-secretase, while the cleavage at V-3 seems to be mediated by [beta]-secretase. Although inhibition of endocytosis enhances the cleavages at both V-3 and I-6, PMA, an alpha-secretase stimulator, treatment enhances neither of these cleavages. Interestingly, a [beta]-secretase inhibitor, z-VLL-CHO, suppressed V-3 but not I-6 cleavage. The pathological [beta]APP Swedish mutant adjacent to the cleavage sites shows similar effects. Our data demonstrate that neither alpha nor [beta]-secretase undergoes extracellular shedding at I-6 of [beta]APP. Therefore, our data may indicate a novel alternative [beta]APP degradation pathway which is up-regulated upon low level of endocytosis.[PUBLICATION ABSTRACT] |
doi_str_mv | 10.1111/j.1479-8301.2006.00142.x |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_232003206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1126818321</sourcerecordid><originalsourceid>FETCH-proquest_journals_2320032063</originalsourceid><addsrcrecordid>eNpjYFAwNNAzBAL9LD1DE3NLXQtjA0M9IwMDMz0DA0MTI70KJgZOuAQLkG1sYqZrbGpgwMHAVVycZWBgZGJqbMzJIOAf5Onu6efoo-AYFOLp7OPKw8CalphTnMoLpbkZlNxcQ5w9dAuK8gtLU4tL4rPyS4vygFLxRsZAC4HYzJgoRQDqSCzR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232003206</pqid></control><display><type>article</type><title>ORIGINAL ARTICLE: Inhibition of endocytosis activates alternative degradation pathway of [beta]APP in cultured cells</title><source>Wiley Online Library All Journals</source><creator>FUKUMORI, Akio ; JIANG, Jingwei ; TANII, Hisashi ; MORIHARA, Takashi ; KAMINO, Kojin ; TANAKA, Toshihisa ; KUDO, Takashi ; ITO, Naohiro ; TAGAMI, Shinji ; OKOCHI, Masayasu ; TAKEDA, Masatoshi</creator><creatorcontrib>FUKUMORI, Akio ; JIANG, Jingwei ; TANII, Hisashi ; MORIHARA, Takashi ; KAMINO, Kojin ; TANAKA, Toshihisa ; KUDO, Takashi ; ITO, Naohiro ; TAGAMI, Shinji ; OKOCHI, Masayasu ; TAKEDA, Masatoshi</creatorcontrib><description>Alzheimer's disease associated [beta]APP is sequentially endoproteolyzed by alpha/[beta]-secretase and gamma-cleavage. In the process, extracellular shedding by alpha-secretase (ADAM 9/10/17) or [beta]-secretase (BACE 1/2) at position L17 or D1 (A[beta] numbering) are prerequisites for the generation of P3 or A[beta], respectively. In addition, several alternative extracellular cleavage sites in [beta]APP have been reported at position I-6, V-3, R5, E11, F20, and A21. Among these sites, position R5 is considered to be cleaved by alpha-secretase-like activity, whereas position E11, F20 and A21 are cleaved by [beta]-secretase. Therefore, extracellular shedding of [beta]APP is thought to be mediated exclusively by alpha/[beta]-secretase activities. However, so far the characteristics of cleavages at position V-3 and I-6 are not well understood. The aim of this study is to characterize these two cleavages of [beta]APP. We analyzed the conditioned media of [beta]APP wt or sw expressing cells with or without pharmacological agents. Here, we show that the cleavage at position I-6 of [beta]APP has characteristics distinct from that of alpha/[beta]-secretase, while the cleavage at V-3 seems to be mediated by [beta]-secretase. Although inhibition of endocytosis enhances the cleavages at both V-3 and I-6, PMA, an alpha-secretase stimulator, treatment enhances neither of these cleavages. Interestingly, a [beta]-secretase inhibitor, z-VLL-CHO, suppressed V-3 but not I-6 cleavage. The pathological [beta]APP Swedish mutant adjacent to the cleavage sites shows similar effects. Our data demonstrate that neither alpha nor [beta]-secretase undergoes extracellular shedding at I-6 of [beta]APP. Therefore, our data may indicate a novel alternative [beta]APP degradation pathway which is up-regulated upon low level of endocytosis.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 1346-3500</identifier><identifier>EISSN: 1479-8301</identifier><identifier>DOI: 10.1111/j.1479-8301.2006.00142.x</identifier><language>eng</language><publisher>Tokyo: Blackwell Publishing Ltd</publisher><subject>Alzheimer's disease ; Cell culture ; Cellular biology ; Enzymes</subject><ispartof>Psychogeriatrics, 2006-09, Vol.6 (3), p.107</ispartof><rights>2006 Japanese Psychogeriatric Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>FUKUMORI, Akio</creatorcontrib><creatorcontrib>JIANG, Jingwei</creatorcontrib><creatorcontrib>TANII, Hisashi</creatorcontrib><creatorcontrib>MORIHARA, Takashi</creatorcontrib><creatorcontrib>KAMINO, Kojin</creatorcontrib><creatorcontrib>TANAKA, Toshihisa</creatorcontrib><creatorcontrib>KUDO, Takashi</creatorcontrib><creatorcontrib>ITO, Naohiro</creatorcontrib><creatorcontrib>TAGAMI, Shinji</creatorcontrib><creatorcontrib>OKOCHI, Masayasu</creatorcontrib><creatorcontrib>TAKEDA, Masatoshi</creatorcontrib><title>ORIGINAL ARTICLE: Inhibition of endocytosis activates alternative degradation pathway of [beta]APP in cultured cells</title><title>Psychogeriatrics</title><description>Alzheimer's disease associated [beta]APP is sequentially endoproteolyzed by alpha/[beta]-secretase and gamma-cleavage. In the process, extracellular shedding by alpha-secretase (ADAM 9/10/17) or [beta]-secretase (BACE 1/2) at position L17 or D1 (A[beta] numbering) are prerequisites for the generation of P3 or A[beta], respectively. In addition, several alternative extracellular cleavage sites in [beta]APP have been reported at position I-6, V-3, R5, E11, F20, and A21. Among these sites, position R5 is considered to be cleaved by alpha-secretase-like activity, whereas position E11, F20 and A21 are cleaved by [beta]-secretase. Therefore, extracellular shedding of [beta]APP is thought to be mediated exclusively by alpha/[beta]-secretase activities. However, so far the characteristics of cleavages at position V-3 and I-6 are not well understood. The aim of this study is to characterize these two cleavages of [beta]APP. We analyzed the conditioned media of [beta]APP wt or sw expressing cells with or without pharmacological agents. Here, we show that the cleavage at position I-6 of [beta]APP has characteristics distinct from that of alpha/[beta]-secretase, while the cleavage at V-3 seems to be mediated by [beta]-secretase. Although inhibition of endocytosis enhances the cleavages at both V-3 and I-6, PMA, an alpha-secretase stimulator, treatment enhances neither of these cleavages. Interestingly, a [beta]-secretase inhibitor, z-VLL-CHO, suppressed V-3 but not I-6 cleavage. The pathological [beta]APP Swedish mutant adjacent to the cleavage sites shows similar effects. Our data demonstrate that neither alpha nor [beta]-secretase undergoes extracellular shedding at I-6 of [beta]APP. Therefore, our data may indicate a novel alternative [beta]APP degradation pathway which is up-regulated upon low level of endocytosis.[PUBLICATION ABSTRACT]</description><subject>Alzheimer's disease</subject><subject>Cell culture</subject><subject>Cellular biology</subject><subject>Enzymes</subject><issn>1346-3500</issn><issn>1479-8301</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpjYFAwNNAzBAL9LD1DE3NLXQtjA0M9IwMDMz0DA0MTI70KJgZOuAQLkG1sYqZrbGpgwMHAVVycZWBgZGJqbMzJIOAf5Onu6efoo-AYFOLp7OPKw8CalphTnMoLpbkZlNxcQ5w9dAuK8gtLU4tL4rPyS4vygFLxRsZAC4HYzJgoRQDqSCzR</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>FUKUMORI, Akio</creator><creator>JIANG, Jingwei</creator><creator>TANII, Hisashi</creator><creator>MORIHARA, Takashi</creator><creator>KAMINO, Kojin</creator><creator>TANAKA, Toshihisa</creator><creator>KUDO, Takashi</creator><creator>ITO, Naohiro</creator><creator>TAGAMI, Shinji</creator><creator>OKOCHI, Masayasu</creator><creator>TAKEDA, Masatoshi</creator><general>Blackwell Publishing Ltd</general><scope>7TK</scope></search><sort><creationdate>20060901</creationdate><title>ORIGINAL ARTICLE</title><author>FUKUMORI, Akio ; JIANG, Jingwei ; TANII, Hisashi ; MORIHARA, Takashi ; KAMINO, Kojin ; TANAKA, Toshihisa ; KUDO, Takashi ; ITO, Naohiro ; TAGAMI, Shinji ; OKOCHI, Masayasu ; TAKEDA, Masatoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2320032063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alzheimer's disease</topic><topic>Cell culture</topic><topic>Cellular biology</topic><topic>Enzymes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FUKUMORI, Akio</creatorcontrib><creatorcontrib>JIANG, Jingwei</creatorcontrib><creatorcontrib>TANII, Hisashi</creatorcontrib><creatorcontrib>MORIHARA, Takashi</creatorcontrib><creatorcontrib>KAMINO, Kojin</creatorcontrib><creatorcontrib>TANAKA, Toshihisa</creatorcontrib><creatorcontrib>KUDO, Takashi</creatorcontrib><creatorcontrib>ITO, Naohiro</creatorcontrib><creatorcontrib>TAGAMI, Shinji</creatorcontrib><creatorcontrib>OKOCHI, Masayasu</creatorcontrib><creatorcontrib>TAKEDA, Masatoshi</creatorcontrib><collection>Neurosciences Abstracts</collection><jtitle>Psychogeriatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FUKUMORI, Akio</au><au>JIANG, Jingwei</au><au>TANII, Hisashi</au><au>MORIHARA, Takashi</au><au>KAMINO, Kojin</au><au>TANAKA, Toshihisa</au><au>KUDO, Takashi</au><au>ITO, Naohiro</au><au>TAGAMI, Shinji</au><au>OKOCHI, Masayasu</au><au>TAKEDA, Masatoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ORIGINAL ARTICLE: Inhibition of endocytosis activates alternative degradation pathway of [beta]APP in cultured cells</atitle><jtitle>Psychogeriatrics</jtitle><date>2006-09-01</date><risdate>2006</risdate><volume>6</volume><issue>3</issue><spage>107</spage><pages>107-</pages><issn>1346-3500</issn><eissn>1479-8301</eissn><abstract>Alzheimer's disease associated [beta]APP is sequentially endoproteolyzed by alpha/[beta]-secretase and gamma-cleavage. In the process, extracellular shedding by alpha-secretase (ADAM 9/10/17) or [beta]-secretase (BACE 1/2) at position L17 or D1 (A[beta] numbering) are prerequisites for the generation of P3 or A[beta], respectively. In addition, several alternative extracellular cleavage sites in [beta]APP have been reported at position I-6, V-3, R5, E11, F20, and A21. Among these sites, position R5 is considered to be cleaved by alpha-secretase-like activity, whereas position E11, F20 and A21 are cleaved by [beta]-secretase. Therefore, extracellular shedding of [beta]APP is thought to be mediated exclusively by alpha/[beta]-secretase activities. However, so far the characteristics of cleavages at position V-3 and I-6 are not well understood. The aim of this study is to characterize these two cleavages of [beta]APP. We analyzed the conditioned media of [beta]APP wt or sw expressing cells with or without pharmacological agents. Here, we show that the cleavage at position I-6 of [beta]APP has characteristics distinct from that of alpha/[beta]-secretase, while the cleavage at V-3 seems to be mediated by [beta]-secretase. Although inhibition of endocytosis enhances the cleavages at both V-3 and I-6, PMA, an alpha-secretase stimulator, treatment enhances neither of these cleavages. Interestingly, a [beta]-secretase inhibitor, z-VLL-CHO, suppressed V-3 but not I-6 cleavage. The pathological [beta]APP Swedish mutant adjacent to the cleavage sites shows similar effects. Our data demonstrate that neither alpha nor [beta]-secretase undergoes extracellular shedding at I-6 of [beta]APP. Therefore, our data may indicate a novel alternative [beta]APP degradation pathway which is up-regulated upon low level of endocytosis.[PUBLICATION ABSTRACT]</abstract><cop>Tokyo</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/j.1479-8301.2006.00142.x</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1346-3500 |
ispartof | Psychogeriatrics, 2006-09, Vol.6 (3), p.107 |
issn | 1346-3500 1479-8301 |
language | eng |
recordid | cdi_proquest_journals_232003206 |
source | Wiley Online Library All Journals |
subjects | Alzheimer's disease Cell culture Cellular biology Enzymes |
title | ORIGINAL ARTICLE: Inhibition of endocytosis activates alternative degradation pathway of [beta]APP in cultured cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A41%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ORIGINAL%20ARTICLE:%20Inhibition%20of%20endocytosis%20activates%20alternative%20degradation%20pathway%20of%20%5Bbeta%5DAPP%20in%20cultured%20cells&rft.jtitle=Psychogeriatrics&rft.au=FUKUMORI,%20Akio&rft.date=2006-09-01&rft.volume=6&rft.issue=3&rft.spage=107&rft.pages=107-&rft.issn=1346-3500&rft.eissn=1479-8301&rft_id=info:doi/10.1111/j.1479-8301.2006.00142.x&rft_dat=%3Cproquest%3E1126818321%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232003206&rft_id=info:pmid/&rfr_iscdi=true |